Stock Earnings

Question 1

Neogenomics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Neogenomics Inc'in toplam varlıkları $1,638 olup, net loss $-78'dir.

Question 2

NEO'ün temel finansal oranları nelerdir?

Accepted Answer

Neogenomics Inc'in cari oranı 2.22, net kâr marjı -11.81, hisse başına satış $5.21'dir.

Question 3

Neogenomics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Neogenomics Inc largest revenue segment is Client Direct Billing, at a revenue of 475,444,000 in the most earnings release.For geography, United States is the primary market for Neogenomics Inc, at a revenue of 660,566,000.

Question 4

Neogenomics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Neogenomics Inc'in net loss $-78'dir.

Question 5

Neogenomics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Neogenomics Inc'in yükümlülüğü 735'dir.

Question 6

Neogenomics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Neogenomics Inc'in toplam tedavüldeki hisse sayısı 128.14'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	709	660	591	509	484	444
Revenue Growth (YoY)	10%	12%	16%	5%	9%	9%
Cost of Revenue	400	370	347	321	297	258
Gross Profit	308	290	244	187	187	185
Selling, General & Admin	351	310	279	277	229	169
Research & Development	35	29	25	28	21	8
Operating Expenses	400	375	341	341	290	197
Other Non Operating Income (Expenses)	0	0	0	0	0	11
Pretax Income	-113	-80	-97	-159	-15	-14
Income Tax Expense	0	-1	-9	-15	-6	-18
Net Income	-113	-78	-87	-144	-8	4
Net Income Growth	47%	-10%	-40%	1,700%	-300%	-50%
Shares Outstanding (Diluted)	128.41	126.65	125.5	124.2	120	111.8
Shares Change (YoY)	1%	1%	1%	4%	7%	8%
EPS (Diluted)	-0.88	-0.62	-0.7	-1.16	-0.07	0.04
EPS Growth	44%	-11%	-40%	1,557%	-275%	-50%
Free Cash Flow	-17	-34	-30	-96	-90	-27
Free Cash Flow Per Share	-0.13	-0.26	-0.23	-0.77	-0.75	-0.24
Gross Margin	43.44%	43.93%	41.28%	36.73%	38.63%	41.66%
Operating Margin	-12.97%	-12.87%	-16.24%	-30.05%	-21.28%	-2.47%
Profit Margin	-15.93%	-11.81%	-14.72%	-28.29%	-1.65%	0.9%
Free Cash Flow Margin	-2.39%	-5.15%	-5.07%	-18.86%	-18.59%	-6.08%
EBITDA	-23	-13	-24	-84	-50	24
EBITDA Margin	-3.24%	-1.96%	-4.06%	-16.5%	-10.33%	5.4%
D&A For EBITDA	69	72	72	69	53	35
EBIT	-92	-85	-96	-153	-103	-11
EBIT Margin	-12.97%	-12.87%	-16.24%	-30.05%	-21.28%	-2.47%
Effective Tax Rate	0%	1.25%	9.27%	9.43%	40%	128.57%

Neogenomics Inc (NEO) Price

NEO Stock Price Chart

NEO Income

Follow-Up Questions